Flowr is offering high quality recreational and medicinal cannabis products
The Flowr Corporation is a Toronto-headquartered cannabis company with operations in Canada, Europe, and Australia. Its Canadian operating campus includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a state-of-the-art R&D facility that is currently under construction. Further, from this campus, Flowr produces recreational and medicinal products. Internationally, Flowr intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and will operate GMP-designed manufacturing facilities in Portugal and Australia.
Moreover, the company aims to support improving outcomes through responsible cannabis use. In fact, as an established expert in cannabis cultivation, they strive to be the brand of choice for consumers and patients seeking the highest-quality craftsmanship and product consistency across a portfolio of differentiated cannabis products.
By combining old-world craftsmanship with state-of-the-art technology, they’re able to offer products with uncompromising quality.
“We have the technical capability to grow plants that are competitive with the illicit market and we have a global footprint for the medicinal market that’s second to none”, says CEO Vinay Tolia.
For more information on The Flowr Corporation (FLWR:TSX.V, FLWPF:OTC) please fill out the form below.